So to answer the two specific questions the member asked—what L data would go to the director-general under new section 35DDI—I was checking to see whether the bill went up to section 35DDT, because that might deal with some of the problems we had, but no, it didn't. But new section 35DDI—the purpose of providing that data to the director-general is again a public health approach: let's build up a profile of the data that's been gathered, the sort of drugs that are being consumed, the risks that are being taken, because that can then inform some broader public policy, public health initiatives to address dangerous or harmful drug consumption. 